<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Osivax Creates Universal Influenza and Coronavirus Vaccine
Image Overlay - Osivax Creates Universal Influenza and Coronavirus Vaccine

Osivax Creates Universal Influenza and Coronavirus Vaccine

July 16, 2020

Osivax Creates Universal Influenza and Coronavirus Vaccine

French biotech Osivax was granted 30 million euros in public funding for the development of a universal vaccine against both influenza and coronavirus. With 21 GMP certified depots located around the world, including Europe, Yourway provides all customers with quality assurance and is focused on regulatory compliance--this is crucial when testing a vaccine around the world.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat
Come chat with us!
Hello! How can I help you?